A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
Clinical trial NCT02135692 · COMPLETED
Trial details
- NCT number
- NCT02135692
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-29
- Primary completion
- 2017-10-05
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.